Coherus Oncology Inc (CHRS)

Net Margin

-144.20%

Quarterly · Period ending:

CHRS logo

CHRS Net Margin

Latest reported-144.20%
CHRS Quarterly Net Margin (-1751.38% → -144.20%)
High-resolution chart · PNG

CHRS net margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Net Margin — Quarterly
Period endingNet Margin
-144.2021%
-308.1966%
-292.4223%
-303.4223%
-403.111%
-744.4269%
-93.6318%
-15.1906%
-19.8849%
4,457.3224%
-87.0296%
-53.1609%
-73.0108%
-233.4721%
-129.8068%
-190.7582%
-83.3735%
-159.8337%
-62.3203%
-46.6989%
-34.1157%
-208.2846%
8.792%
24.5995%
43.5094%
30.618%
31.6715%
42.1215%
28.2466%
-53.922%
0%
0%
0%
0%
0%
0%
-3,966.7384%
-46,445.9627%
-8,995.3791%
51.5485%
-497.3486%
-529.0719%
-513.738%
-995.3118%
-856.5395%
-700.9466%
-448.6986%
-49.0406%
-502.6586%
-699.9444%
-1,184.3344%
-4,243.6759%
-1,717.7515%
-1,751.3834%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.